Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and life sciences industries worldwide. The Company's products include Luminex LX 100/200 that integrates fluidics, optics, and digital signal processing, FLEXMAP 3D system for use as a general laboratory instrument, and other diagnostics systems and platforms. It also offers laboratory software suites and data management software solutions. In addition, the Company provides reagents, assays and test cartridges for various purposes. Further, it offers specialty product family and instrumentation products, as well as operates as an original equipment manufacturer of custom reagents and instrumentation.

Austin, US
Size (employees)
914 (est)
Luminex was founded in 1995 and is headquartered in Austin, US
Report incorrect company information

Luminex Office Locations

Luminex has offices in Hong Kong, Shanghai, Northbrook, Austin and in 4 other locations
Austin, US (HQ)
12212 Technology Blvd, Suite 130
Madison, US
1224 Deming Way
Northbrook, US
4088 Commercial Ave
Toronto, CA
439 University Ave Suite 900
Shanghai, CN
14/F C&D, Building 7, Pujiang Hi-Tech Park 2388 Chenhang Road, Minhang District
Hong Kong, HK
Unit 1206, Lemmi Centre 50 Hoi Yuen Road
Show all (8)
Report incorrect company information

Luminex Financials and Metrics

Luminex Financials

Luminex's revenue was reported to be $270.64 m in FY, 2016 which is a 13.9% increase from the previous period.

Revenue (Q2, 2017)

76.5 m

Gross profit (Q2, 2017)

50.1 m

Gross profit margin (Q2, 2017), %


Net income (Q2, 2017)

5.5 m

EBIT (Q2, 2017)

7.5 m

Market capitalization (23-Apr-2018)

960 m

Cash (30-Jun-2017)

103.7 m
Luminex's current market capitalization is $960 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016


10.7 m227 m237.7 m270.6 m

Revenue growth, %


Cost of goods sold

69.8 m67.1 m69 m91 m

Gross profit

(59.1 m)159.9 m168.7 m179.7 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017


50.8 m56.6 m55.6 m56.7 m57.7 m58.9 b60.6 b63 m64.2 m71.2 m77.8 m76.5 m

Cost of goods sold

20 m16.6 m17.5 m17.7 m17.5 m15.6 b18.8 b18.2 m19.2 m25.6 m25 m26.4 m

Gross profit

30.8 m40 m38.1 m39 m40.2 m43.3 b41.8 b44.8 m44.9 m45.7 m52.8 m50.1 m

Gross profit Margin, %

usdY, 2009Y, 2010Y, 2011Y, 2012Y, 2013Y, 2014Y, 2015FY, 2016


90.8 m89.5 m58.3 m42.8 m67.9 m91.7 m128.5 m93.5 m

Accounts Receivable

30.9 m29.1 m28.9 m32.4 m


40.8 m

Current Assets

146.4 m177 m209.5 m173.7 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017


57.2 m77.4 m86.7 m89.1 m94.9 m111.1 m119.6 m134.3 m81.7 m84.1 m86.5 m103.7 m

Accounts Receivable

30.2 m27 m27.6 m27.4 m25.1 m22.2 m26.2 m29.4 m27 m30 m37 m33.1 m


29.7 m30.9 m31.2 m33.1 m33.7 m32.6 m29.3 m31.2 m41.5 m41.5 m43.7 m47.1 m

Current Assets

130 m150.3 m157.5 m163.1 m172.2 m192.7 m201.9 m217.7 m159.2 m164.9 m173.5 m192.1 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

7.1 m39 m36.9 m13.8 m

Depreciation and Amortization

15.9 m14.2 m

Accounts Payable

962 k841 k
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

796 k6 m4.7 m5.6 m7.5 m2.6 b6.4 b8.8 m5.7 m2.8 m9.2 m

Accounts Payable

8.9 m10.1 m11 m8 m9.3 m6.9 m11.3 m9.9 m9.1 m

Income Taxes Paid

(1.6 m)(2.2 m)(45 k)(2.9 m)
USDY, 2017

Financial Leverage

1.1 x
Show all financial metrics

Luminex Operating Metrics

FY, 2015FY, 2016

Patents Issued

364 563

Patents Pending

199 166
Show all operating metrics
Report incorrect company information

Luminex News and Updates

Global SNP Genotyping Highlights Market Size, Opportunities, Trends and Forecast 2022

The report provides in depth study of “SNP Genotyping” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information